SHAREHOLDERS' MEETING ON 28 APRIL 2025 Summary report on voting at Shareholders' Meeting Shares represented at the Shareholders' Meeting: 17.859.124 equal to 63,49% of the share capital Agenda
POINT 1
Balance sheet as of 31/12/2024:
Favorable shares | 17.859.124 equal to 63,49% of the share capital |
Contrary shares | 0 |
Non-voting shares | 0 |
POINT 2
Allocation of profit of the period 2024:
Favorable shares | 17.859.124 equal to 63,49% of the share capital |
Contrary shares | 0 |
Non-voting shares | 0 |
POINT 3 Consolidated balance sheet as of 31/12/2024
Point 2 does not require votes from shareholders.
POINT 3
Appointment of the Board of Directors for the years 2025-2026-2027 Majority shareholder Aequafin SpA's list
Favorable shares | 17.835.834 equal to 63,41% of the share capital |
Contrary shares | 0 |
Non-voting shares | 23.290 equal to 0,08% of the share capital |
POINT 4
Determination of the annual remuneration for the members of the Board of Directors;
Favorable shares | 17.833.499 equal to 63,40% of the share capital |
Contrary shares | 23.290 equal to 0,08% of the share capital |
Non-voting shares | 2.335 equal to 0,01% of the share capital |
POINT 5
Proposal of authorization to the purchase and hold of own shares, how to purchase and to sale.
Favorable shares | 17.835.834 equal to 63,41% of the share capital |
Contrary shares | 23.290 equal to 0,08% of the share capital |
Non-voting shares | 0 |
POINT 6
Report on remuneration pursuant to art.123-ter TUF, first section, binding resolution:
Favorable shares | 17.835.834 equal to 63,41% of the share capital |
Contrary shares | 23.290 equal to 0,08% of the share capital |
Non-voting shares | 0 |
POINT 7
Report on remuneration pursuant to art.123-ter TUF, second section, non-binding resolution:
Favorable shares | 17.835.834 equal to 63,41% of the share capital |
Contrary shares | 23.290 equal to 0,08% of the share capital |
Non-voting shares | 0 |
Imola, 28 April 2025 IRCE SPA